Levofloxacin film-coated tablets 250 mg No. 10
Levofloxacin tablets are indicated for the treatment of infections caused by levofloxacin-sensitive microorganisms:
acute bacterial sinusitis; exacerbation of chronic bronchitis; community-acquired pneumonia; complicated skin and soft tissue infections (in the case of the treatment of the above infections, the drug is used only when the use of other antibacterial agents, which are usually prescribed for the initial treatment of these infections, is impossible); complicated urinary tract infections (including pyelonephritis); chronic bacterial prostatitis; uncomplicated cystitis; pulmonary anthrax: post-exposure prophylaxis and treatment.Composition
Active ingredient: 1 tablet contains 256.23 mg of levofloxacin hemihydrate, which is equivalent to 250 mg of levofloxacin;
1 tablet contains 512.46 mg of levofloxacin hemihydrate, which is equivalent to 500 mg of levofloxacin;
Excipients: hypromellose, crospovidone, microcrystalline cellulose, sodium stearyl fumarate, polyethylene glycol 6000, talc, red iron oxide (E172), yellow iron oxide (E172), titanium dioxide (E171).
Contraindication
Hypersensitivity to levofloxacin, other fluoroquinolones or to any component of the drug; epilepsy; tendon damage associated with previous use of fluoroquinolones; children's age; pregnancy and breastfeeding.Method of application
The drug is intended for oral use. The tablets should be swallowed without chewing, with sufficient liquid. The drug can be taken regardless of meals.
The drug should be used at least 2 hours before or after the use of iron salts, zinc salts, antacids containing magnesium or aluminum, didanosine (only for forms containing aluminum or magnesium in buffering agents) and sucralfate.
Application features
Pregnant women
Contraindicated.
Children
Contraindicated.
Drivers
With caution.
Overdose
Symptoms: central nervous system disorders (confusion, dizziness, impaired consciousness and seizures, hallucinations and tremors), digestive system disorders (nausea and erosion of mucous membranes), possible prolongation of the QT interval.
Treatment: symptomatic therapy. ECG monitoring should be carried out, as QT interval prolongation is possible. Antacids are used to protect the gastric mucosa. Hemodialysis, including peritoneal dialysis or HAPD, is not effective in removing levofloxacin from the body. There is no specific antidote.
Side effects
On the part of the psyche: often (from> 1/100 to <1/10) - insomnia.
From the nervous system: often (from> 1/100 to <1/10) - headache, dizziness.
Gastrointestinal: often (from > 1/100 to <1/10) - diarrhea, nausea, vomiting.
On the part of the liver: sometimes (from> 1/100 to <1/10) - increased activity of liver enzymes (ALT / AST, alkaline phosphatase, GGTP).
Interaction
Clinical pharmacology studies have demonstrated that no clinically significant effect on the pharmacokinetics of levofloxacin was caused when levofloxacin was used together with the following drugs: calcium carbonate, digoxin, glibenclamide, ranitidine.
Storage conditions
Store at a temperature not exceeding 30 °C.
Keep out of reach of children.
Shelf life - 3 years.
There are no reviews for this product.
There are no reviews for this product, be the first to leave your review.
No questions about this product, be the first and ask your question.